I
IDXX
IDEXX Laboratories
563.57
+4.97+0.89%After Hours: 565.12 +1.55 +0.28%16:29 07/10 EDT
OPEN/PREV CLOSE561.93/558.60
TODAY RANGE559.72-573.02
VOL612.53K
MARKET CAP44.46B
52 WEEK RANGE506.91-769.98
AVG VOL (3M)643.37K
% TURNOVER0.78%
TURNOVER--
P/E (TTM)41.32
% RANGE2.35%
EPS(TTM)13.64
P/E(FORWARD)38.34
P/B28.70
BVPS19.64
DIVIDEND--
P/S10.44
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP44.34B
SHARES OUTSTANDING78.88M
NEXT EARNINGS08/03-08/07
FREE FLOAT78.67M
LOT SIZE1
EX-DATE06/16/2015
News
Press Releases
Financial Reports
Profile
Simply Wall St·3d ago
Why IDEXX Laboratories (IDXX) Could Be 22% Undervalued After Russell Index Additions
Simply Wall St·07/02 04:47
Does IDEXX’s Broad Russell Value Inclusion Recast Its Defensive Profile and Valuation Story (IDXX)?
PUBT·07/01 20:00
IDEXX Laboratories updates financial calendar
Dow Jones·06/25 20:33
Revvity Inc. Stock Advances 7.5%, Outperforms Peers
Dow Jones·06/24 20:34
Revvity Inc. Stock Rallies 5.7%, Outperforms Peers
Simply Wall St·06/24 19:32
Are IDEXX Laboratories’ (IDXX) New SDMA and Tapeworm Tests Deepening Its Diagnostics Moat?
Dow Jones·06/17 20:35
IDEXX Laboratories Inc. Stock Falls 4.7%, Underperforms Peers
Simply Wall St·06/17 02:25
IDEXX Laboratories (IDXX) Stock Could Be 23.6% Undervalued as Growth Narrative Faces P/E Test
Simply Wall St·06/08 13:25
Is IDEXX’s Broader Parasite Panel Quietly Reshaping the Diagnostics Narrative for IDXX?
Simply Wall St·06/05 17:34
A Look At Idexx Laboratories (IDXX) Valuation After Earnings Beat, Outlook Upgrade And Product Expansion